PRRT2 and cancer: Members of the three PKC classes (“conventional/classical” cPKCs α, β, and γ; “novel” nPKCs δ, ε, η, and θ; and “atypical” aPKCs ζ and ι) have been widely implicated in fundamental cancer-driving events, such as cell proliferation, survival, motility, and invasion.